4P-025

N/A

Report date: 2024/05/27 17:06:51

Base Information

Drug Name4P-025
Drug Alias Name4P-0254P025
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver DiseasesCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies4P-Pharma Ltd
China Registration ClassN/A

Develop Information

Active Companies4P-Pharma Ltd
Inactive CompaniesN/A
Active IndicationsLiver DiseasesCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A